Effects of beta-cyclodextrin on the structure of sphingomyelin/cholesterol model membranes.
The interaction of beta-cyclodextrin (beta-CD) with mixed bilayers composed of sphingomylein and cholesterol (Chol) above and below the accepted stable complexation ratio (67:33) was investigated. Membranes with the same (symmetric) and different (asymmetric) compositions in their inner and outer leaflets were deposited at surface pressures of 20, 30, and 40 mN/m at the solid-liquid interface. Using neutron reflectometry, membranes of various global molar ratios (defined as the sum of the molar ratios of the inner and outer leaflets), were characterized before and after beta-CD was added to the subphase. The structure of bilayers with global molar ratios at or above the stable complexation ratio was unchanged by beta-CD, indicating that beta-CD is unable to remove sphingomyelin or complexed Chol. However, beta-CD removed all uncomplexed Chol from bilayers composed of global molar ratios below the stable complexation ratio. The removal of Chol by beta-CD was independent of the initial structure of the membranes as deposited, suggesting that asymmetric membranes homogenize by the exchange of molecules between leaflets. The interaction of beta-CD with the aforementioned membranes was independent of the deposition surface pressure except for a symmetric 50:50 membrane deposited at 40 mN/m. The scattering from 50:50 bilayers with higher packing densities (deposited at 40 mN/m) was unaffected by beta-CD, suggesting that the removal of Chol can depend on both the composition and packing density of the membrane.
Jablin
Michael S
MS
Lujan Neutron Scattering Center, Los Alamos National Laboratory, Los Alamos, New Mexico, USA.
Flasiński
Michał
M
Dubey
Manish
M
Ratnaweera
Dilru R
DR
Broniatowski
Marcin
M
Dynarowicz-Łatka
Patrycja
P
Majewski
Jarosław
J
D000818:Animals; D002462:Cell Membrane / Q000737:chemistry* / Q000187:drug effects* / Q000378:metabolism; D002784:Cholesterol / Q000737:chemistry* / Q000378:metabolism; D008051:Lipid Bilayers / Q000737:chemistry / Q000378:metabolism; D008958:Models, Molecular; D008968:Molecular Conformation; D033363:Neutron Diffraction; D013109:Sphingomyelins / Q000737:chemistry* / Q000378:metabolism; D047392:beta-Cyclodextrins / Q000378:metabolism / Q000494:pharmacology*
D008051:Lipid Bilayers; D013109:Sphingomyelins; D047392:beta-Cyclodextrins; D002784:Cholesterol
Phys Rev Lett. 2009 Jun 5;102(22):228102
19658904
J Cell Biol. 1997 Dec 15;139(6):1447-54
9396750
Phys Rev B Condens Matter. 1995 Oct 15;52(15):10827-10830
9980180
Phys Rev B Condens Matter. 1995 May 1;51(17):11296-11309
9977855
Biochim Biophys Acta. 2000 Nov 23;1508(1-2):182-95
11090825
Biochimie. 2007 Feb;89(2):192-6
16935406
Biochemistry. 1996 Jun 18;35(24):8018-24
8672506
J Biol Chem. 1996 Jul 5;271(27):16026-34
8663188
Langmuir. 2009 Apr 7;25(7):4181-9
19714835
Chem Rev. 1998 Jul 30;98(5):1743-1754
11848947
J Am Chem Soc. 2009 Mar 18;131(10):3631-8
19275260
Prog Lipid Res. 2002 Jan;41(1):66-97
11694269
Science. 1972 Feb 18;175(4023):720-31
4333397
Biochim Biophys Acta. 1996 Jan 12;1278(1):89-97
8611612
J Biol Chem. 1995 Jul 21;270(29):17250-6
7615524
Biophys J. 1999 Feb;76(2):908-15
9929492
Biochim Biophys Acta. 2008 Jan;1778(1):175-84
18068686
Chem Phys Lipids. 1999 Nov;102(1-2):13-27
11001557
Chem Phys Lipids. 2000 Apr;105(2):167-78
10823464
Langmuir. 2008 Sep 2;24(17):9616-22
18672913
Biophys J. 2004 Feb;86(2):861-9
14747321
J Lipid Res. 1997 Nov;38(11):2264-72
9392424
Biophys J. 1999 Apr;76(4):2142-57
10096908
Nat Rev Mol Cell Biol. 2005 Mar;6(3):209-20
15738987
Biophys J. 2003 Sep;85(3):1656-66
12944280
Biophys J. 1999 Sep;77(3):1507-17
10465761
Colloids Surf B Biointerfaces. 2007 Aug 1;58(2):218-24
17481863
Phys Rev Lett. 2009 Jul 10;103(2):028103
19659249
FEBS Lett. 2007 May 22;581(11):2098-104
17382322
EMBO J. 2000 Mar 1;19(5):892-901
10698931
Biochim Biophys Acta. 2007 Jun;1768(6):1311-24
17493580
Arch Virol. 2009;154(4):595-600
19288237
Nature. 1997 Jun 5;387(6633):569-72
9177342